SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 598 filers reported holding SEAGEN INC in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $484,126 | -18.9% | 2,282 | -22.6% | 0.00% | 0.0% |
| Q1 2023 | $597,287 | +42.3% | 2,950 | -9.7% | 0.00% | 0.0% |
| Q4 2022 | $419,842 | -4.4% | 3,267 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $439,000 | -19.3% | 3,212 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $544,000 | +11.0% | 3,073 | -9.8% | 0.00% | 0.0% |
| Q1 2022 | $490,000 | -1.4% | 3,405 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $497,000 | -12.5% | 3,217 | -3.8% | 0.00% | 0.0% |
| Q3 2021 | $568,000 | -20.8% | 3,343 | -26.4% | 0.00% | -50.0% |
| Q2 2021 | $717,000 | +63.0% | 4,544 | +43.5% | 0.00% | +100.0% |
| Q1 2021 | $440,000 | -95.8% | 3,167 | -94.7% | 0.00% | -97.1% |
| Q4 2020 | $10,475,000 | – | 59,811 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |